Price target
13.350.00 0.00%
The 15 analysts offering 1 year price forecasts for 8EM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 18 analysts giving stock ratings to 8EM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
8EM EPS for the last quarter is −0.69 CHF despite the estimation of −0.56 CHF. In the next quarter EPS is expected to reach −0.63 CHF. Track more of EDITAS MEDICINE IN financials and stay on top of what is up with the company.
In the next quarter EDITAS MEDICINE IN revenue is expected to reach 4.01 M CHF. Check out EDITAS MEDICINE IN revenue and earnings and make informed decisions.
According to analysts, 8EM price target is 13.35 CHF with a max estimate of 24.68 CHF and a min estimate of 6.40 CHF. Check if this forecast comes true in a year, meanwhile watch EDITAS MEDICINE IN stock price chart and keep track of the current situation with 8EM news and stock market news.
We've gathered opinions of 18 analysts rating 8EM stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.